SCHEMBL16241024

SCHEMBL16241024

CCn1c2ccccc2c2cc(B(O)OC(C)(C)C(C)(C)O)ccc21

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 10/20 0.47
KDM4E B2RXH2 9/20 0.47
HPGD P15428 4/20 0.47
MEN1 O00255 3/20 0.47
KMT2A Q03164 3/20 0.47
ALDH1A1 P00352 3/20 0.47
HTT P42858 2/20 0.47
MAPK1 P28482 2/20 0.47
HSD17B10 Q99714 2/20 0.47
HBB P68871 1/20 0.47
TDP1 Q9NUW8 1/20 0.47
LMNA P02545 6/20 0.44
POLB P06746 2/20 0.44
PKM P14618 1/20 0.44
NPSR1 Q6W5P4 1/20 0.43
NPY5R Q15761 2/20 0.43
SRC P12931 2/20 0.43
SMN1; SMN2 Q16637 2/20 0.42
RORC P51449 1/20 0.41
CASP1 P29466 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16819120 0.87 CYP19A1 (0.48) MAPTKDM4EMEN1KMT2AALDH1A1
SCHEMBL16819113 0.86 KDM4E (0.44) MAPTKDM4EHPGDMEN1KMT2A
SCHEMBL11969957 0.83 KDM4E (0.44) MAPTKDM4EHPGDMEN1KMT2A
SCHEMBL3455207 0.79
SCHEMBL29825702 0.79 KDM4E (0.59) MAPTKDM4EHPGDMEN1KMT2A
SCHEMBL16470931 0.79 KDM4E (0.59) MAPTKDM4EHPGDMEN1KMT2A
SCHEMBL18669434 0.76 KDM4E (0.42) KDM4EHPGDKMT2AALDH1A1POLB
SCHEMBL19514665 0.74 MEN1 (0.40) MAPTKDM4EHPGDMEN1KMT2A
SCHEMBL15940278 0.73 KIF11 (0.33) MAPTKDM4EHPGDALDH1A1HSD17B10
SCHEMBL15940009 0.72 PSEN1 (0.43)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-106471094-B Pi-conjugated semiconductor organic glass mixture for OLED and OED 分子玻璃公司 2021-04-20 CN disclosed
US-10240084-B2 Non-crystallizable pi-conjugated molecular glass mixtures, charge transporting molecular glass mixtures, luminescent molecular glass mixtures, or combinations thereof for organic light emitting diodes and other organic electronics and photonics applications MOLECULAR GLASSES, INC. (US) 2019-03-26 US disclosed
US-10109806-B2 Organometallic complex, light-emitting element, light-emitting device, electronic appliance, and lighting device SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) 2018-10-23 US disclosed
EP-3122841-A2 PI-CONJUGATED SEMICONDUCTIVE ORGANIC GLASS MIXTURES FOR OLED AND OEDS Molecular Glasses, Inc. (US) 2017-02-01 EP disclosed
US-20150275076-A1 Non-crystallizable Pi-conjugated Molecular Glass Mixtures, Charge Transporting Molecular Glass Mixtures, Luminescent Molecular Glass Mixtures, or Combinations Thereof for Organic Light Emitting Diodes and other Organic Electronics and Photonics Applications Molaire Consulting 2015-10-01 US disclosed
WO-2015148327-A2 PI-CONJUGATED SEMICONDUCTIVE ORGANIC GLASS MIXTURES FOR OLED AND OEDS MOLAIRE CONSULTING LLC (US) 2015-10-01 WO disclosed
US-20140339526-A1 ORGANOMETALLIC COMPLEX, LIGHT-EMITTING ELEMENT, LIGHT-EMITTING DEVICE, ELECTRONIC APPLIANCE, AND LIGHTING DEVICE SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) 2014-11-20 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10109806-B2 Organometallic complex, light-emitting element, light-emitting device, electronic appliance, and lighting device LIG4, LIG3, LIG1 MAPT 2017/4885KDM4E 303/4885HPGD 3358/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.